跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 13,368 条关于
“NMDA receptor subtype NR2B”
全部
13,368
临床试验
6,266
药物
1,390
机构
31
资讯
5,681
去年
GNT Pharma's Nelonemdaz Shows Promise in Improving Stroke Outcomes with Early Administration
去年
FDA Grants Breakthrough Therapy Status to Radiprodil for GRIN-Related Seizure Treatment
去年
Novel NMDA Receptor Modulator Onfasprodil Shows Rapid Antidepressant Effects with Reduced Side Effects in Phase 2 Trial
去年
AXS-05, a Novel NMDA Receptor Antagonist, Shows Promise for Agitation in Alzheimer's Disease
3个月前
SLC6A20-Targeting ASO Restores NMDA Receptor Function in Autism Models, Offering New Therapeutic Strategy
去年
NMDA Receptor Research Reveals Novel Mechanism for Brain Stabilization and Potential Depression Treatments
2年前
Radiprodil Shows Promise in Reducing Seizure Frequency in GRIN-Related Neurodevelopmental Disorder
10个月前
Neurocrine's NBI-1070770 Fails to Meet Primary Endpoint in Phase II Major Depressive Disorder Trial
去年
GRIN Therapeutics Initiates Radiprodil Trial for Seizures in TSC and FCD
去年
Avutometinib and Defactinib Rolling NDA Completed for KRAS-Mutated Low-Grade Serous Ovarian Cancer
第 1 页，共 569 页
上一页
下一页
